Today is August 14, 2024.
All times in Eastern Daylight Time.
-
SilverBow Resources Stockholders Approve Acquisition by Crescent Energy
HOUSTON--(BUSINESS WIRE)--SilverBow Resources, Inc. (NYSE: SBOW) (“SilverBow” or the “Company”) today announced that, at a special meeting of stockholders earlier today (the “Special Meeting”), its... more »
-
AMERISAFE Announces 2024 Second Quarter Results
DERIDDER, La.--(BUSINESS WIRE)--AMERISAFE ANNOUNCES 2024 SECOND QUARTER RESULTS more »
-
Pulse Biosciences Schedules Second Quarter 2024 Financial Results Conference Call for August 12, 2024
MIAMI--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced it will report ... more »
-
Amneal Receives U.S. FDA Approval for Potassium Phosphates Injection IV Bags
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that it has received New Drug Application (“NDA”) approval from the U.S. ... more »
-
CEL-SCI Announces Closing of $10.8 Million Offering
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI announces closing of $10.8 million offering. more »
-
Caliber Announces Second Quarter 2024 Earnings Release and Conference Call
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Caliber to issue its second quarter 2024 earnings report on August 12, 2024. more »
-
NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) (the “Company” or “NovaBay”) today announced the closing of its previously announced underwritten public offe... more »
-
F5 Reports Third Quarter Fiscal Year 2024 Revenue at the Top End of its Guidance Range; Expects Fiscal Year 2024 Revenue of ~$2.8 Billion Based on Software Strength; Raises Earnings Growth Outlook
SEATTLE--(BUSINESS WIRE)--F5, Inc. (NASDAQ: FFIV) today announced financial results for its third quarter ended June 30, 2024. “We delivered third quarter revenue at the top end of our guidance ran... more »
-
Central Garden & Pet to Announce Q3 Fiscal 2024 Financial Results
WALNUT CREEK, Calif.--(BUSINESS WIRE)--Central Garden & Pet Company (NASDAQ: CENT) (NASDAQ: CENTA) (“Central”), a market leader in the Pet and Garden industries, will announce results for its f... more »
-
Amkor Technology Reports Financial Results for the Second Quarter 2024
TEMPE, Ariz.--(BUSINESS WIRE)--Amkor Technology Reports Financial Results for the Second Quarter 2024 more »
-
HomeStreet Reports Second Quarter 2024 Results
SEATTLE--(BUSINESS WIRE)--HomeStreet Reports Second Quarter 2024 Results more »
-
Rambus Expands Industry-Leading Memory Interface Chip Offering to High-Performance PCs with DDR5 Client Clock Driver
SAN JOSE, Calif.--(BUSINESS WIRE)--Today, Rambus announced the availability of its DDR5 Client Clock Driver (CKD) for next-generation, high-performance desktops and notebooks. more »
-
Sprouts Farmers Market, Inc. Reports Second Quarter 2024 Results
PHOENIX--(BUSINESS WIRE)--Sprouts Farmers Market, Inc. (Nasdaq: SFM) today reported results for the 13-week second quarter ended June 30, 2024. "Sprouts saw outstanding second quarter results, than... more »
-
SBA Communications Corporation Reports Second Quarter 2024 Results; Updates Full Year 2024 Outlook; and Declares Quarterly Cash Dividend
BOCA RATON, Fla.--(BUSINESS WIRE)--SBA Communications Corporation (Nasdaq: SBAC) ("SBA" or the "Company") today reported results for the quarter ended June 30, 2024. Highlights of the second quarte... more »
-
ATSG Delivers Two Boeing 767s to Georgian Airways
WILMINGTON, Ohio--(BUSINESS WIRE)--ATSG announced today that its leasing subsidiary recently delivered two Boeing 767-300 aircraft to Georgian Airways LLC of Tbilisi, Georgia. more »
-
Verastem Oncology Receives FDA Orphan Drug Designation for Avutometinib and Defactinib for the Treatment of Pancreatic Cancer
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients, today announced that the U.S. Food and Drug Administration ... more »
-
Sensata Technologies Reports Second Quarter 2024 Financial Results
SWINDON, United Kingdom--(BUSINESS WIRE)--Sensata Technologies (NYSE: ST) reports second quarter 2024 financial results. more »
-
Hologic Announces Financial Results for Third Quarter of Fiscal 2024
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic Announces Financial Results for Third Quarter of Fiscal 2024 more »
-
Transcat Reports Strong First Quarter Results with Significant Gross Margin Expansion and EBITDA Growth
ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration services, cost control and optimization services, and dis... more »
-
Member of White House Council of Economic Advisers Visits Belden to Witness Significant Investments in Made in America Initiatives
ST. LOUIS--(BUSINESS WIRE)--Belden Inc. (NYSE: BDC), a leading global supplier of network infrastructure and digitization solutions, was excited to welcome Dr. Heather Boushey, a member of the Whit... more »
-
4D Molecular Therapeutics, Inc. (FDMT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of 4D Molecular Therapeutics, Inc. (“4D Molecular” ... more »
-
Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Morphic Holding, Inc. (“Morphic”) (NASDAQ: MORF) and Eli Lilly and Compan... more »
-
Johnson & Johnson to Participate in the 2024 Wells Fargo Healthcare Conference
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will participate in the 2024 Wells Fargo Healthcare Conference on Thursday, September 5th, at the Encore Boston Harbor, Evert... more »
-
FirstSun Capital Bancorp Reports Second Quarter 2024 Results
DENVER--(BUSINESS WIRE)--FirstSun Capital Bancorp (“FirstSun”) (NASDAQ: FSUN) reported net income of $24.6 million for the second quarter of 2024 compared to net income of $28.0 million for the sec... more »
-
Lattice Semiconductor Reports Second Quarter 2024 Results
HILLSBORO, Ore.--(BUSINESS WIRE)--Lattice Semiconductor Corporation (Nasdaq: LSCC), the low power programmable leader, announced financial results today for the fiscal second quarter ended June 29,... more »
|
|